Skip to main content

1 Result(s)

within Paula I. Gonzalez-Ericsson Remove this filter Biomedicine, general Remove this filter Cell Biology Remove this filter Human Genetics Remove this filter

and

  1. Article

    Open Access

    PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer

    Clinical trials have demonstrated the efficacy of combining phosphoinositide 3-kinase (PI3K) inhibitors with endocrine therapies in hormone therapy-refractory breast cancer. However, biomarkers of PI3K pathway...

    Mellissa J. Nixon, Luigi Formisano, Ingrid A. Mayer… in npj Breast Cancer (2019)

    Download PDF (2172 KB) View Article